Crohn's Disease

Study results demonstrate diet may differentially influence the gut microbiome in children with Crohn’s disease, according to a presentation at the Crohn’s and Colitis Congress.

A presentation at the Crohn’s and Colitis Congress, highlighted recent updates on dietary therapy for inflammatory bowel disease.

Older patients with inflammatory bowel disease who initiate Entyvio therapy had lower risk for hospitalization than those treated with anti-TNF, according to research presented at the Crohn’s and Colitis Congress.

Researchers developed a wearable sweat senser device that may improve treatment of inflammatory bowel disease, according to a presenter at the virtual Crohn’s and Colitis Congress.

A machine learning image model describing Crohn’s disease phenotypes may impact individualized care for children with Crohn’s, according to a presenter at the Crohn’s and Colitis Congress.

A presenter at the Crohn’s and Colitis Congress highlighted the importance of biomarkers in determining disease activity in inflammatory bowel disease, especially in the era of COVID-19.

Anticoagulation use or antiplatelet agents were not risk factors for gastrointestinal bleeding in hospitalized COVID-19 patients, according to a study published in Journal of Internal Medicine.

First-line Remicade therapy was superior to conventional treatment in achieving short-term remission in children with Crohn’s disease, according to study results.

In this exclusive video, Anita Afzali, MD, director of the inflammatory bowel disease center at The Ohio State University, discusses the impact of emerging therapies in IBD.

In this exclusive video, Freddy Caldera, DO, MS, assistant professor of medicine in the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine and Public Health, spoke about the two recent COVID-19 vaccines that have been authorized for emergency use.